Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma

NCT04385654 is registered in ClinicalTrials.gov with West China Hospital as lead sponsor.

NCT NCT04385654
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04385654 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma
Lead sponsor
West China Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
June 30, 2020
Completion date
June 30, 2022
Enrollment
40 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

advanced cancer, metastatic kidney cancer, neoadjuvant therapy